MicroRNA-9 and microRNA-326 regulate human dopamine D2 receptor expression, and the microRNA-mediated expression regulation is altered by a genetic variant

NIH Image to ImageJ: 25 years of image analysis

Schneider, C. A., Rasband, W. S., & Eliceiri, K. W. (2012) · Nature Methods · doi:10.1038/nmeth.2089 · Cited by 64,638 · see citing works

Haploview: analysis and visualization of LD and haplotype maps

Barrett, J., Fry, B., Maller, J., & Daly, M. (2005) · Bioinform. · doi:10.1093/bioinformatics/bth457 · Cited by 15,086 · see citing works

Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets

Lewis, B. P., Burge, C. B., & Bartel, D. P. (2005) · Cell · doi:10.1016/j.cell.2004.12.035 · Cited by 11,855 · see citing works

Combinatorial microRNA target predictions

Krek, A., Grün, D., Poy, M. N., Wolf, R., Rosenberg, L., Epstein, E. J., MacMenamin, P., da Piedade, I., Gunsalus, K. C., Stoffel, M., et al. (2005) · Nature Genetics · doi:10.1038/ng1536 · Cited by 4,603 · see citing works

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

Chen, J., Mandel, E. M., Thomson, J. M., Wu, Q., Callis, T. E., Hammond, S. M., Conlon, F. L., & Wang, D.-Z. (2005) · Nature Genetics · doi:10.1038/ng1725 · Cited by 2,763 · see citing works

Fast and effective prediction of microRNA/target duplexes

REHMSMEIER, M., STEFFEN, P., HÖCHSMANN, M., & GIEGERICH, R. (2004) · RNA · doi:10.1261/rna.5248604 · Cited by 2,560 · see citing works

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220 · see citing works

Effect of Chlorpromazine or Haloperidol on Formation of 3‐Methoxytyramine and Normetanephrine in Mouse Brain

Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,156 · see citing works

Genome-wide association study identifies five new schizophrenia loci

The Schizophrenia Psychiatric Genome-Wide Association Study (GWAS) Consortium (2011) · Nature Genetics · doi:10.1038/ng.940 · Cited by 1,919 · see citing works

Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson’s disease

Kriks, S., Shim, J., Piao, J., Ganat, Y. M., Wakeman, D. R., Xie, Z., Carrillo‐Reid, L., Auyeung, G., Antonacci, C. L., Buch, A., et al. (2011) · Nature · doi:10.1038/nature10648 · Cited by 1,912 · see citing works

A brain-specific microRNA regulates dendritic spine development

Schratt, G. M., Tuebing, F., Nigh, E. A., Kane, C. G., Sabatini, M. E., Kiebler, M., & Greenberg, M. E. (2006) · Nature · doi:10.1038/nature04367 · Cited by 1,786 · see citing works

MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship

Pasquinelli, A. E. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3162 · Cited by 1,587 · see citing works

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

Multicenter Genetic Studies of Schizophrenia Consortium, Ripke, S., Psychosis Endophenotypes International Consortium, Wellcome Trust Case Control Consortium 2, O'Dushlaine, C., Chambert, K., Moran, J. L., Kähler, A. K., Akterin, S., Bergen, S. E., et al. (2013) · Nature Genetics · doi:10.1038/ng.2742 · Cited by 1,496 · see citing works

Positron Emission Tomographic Analysis of Central D1 and D2 Dopamine Receptor Occupancy in Patients Treated With Classical Neuroleptics and Clozapine

Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,420 · see citing works

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

Laruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · see citing works

Common variants on chromosome 6p22.1 are associated with schizophrenia

Shi, J., Levinson, D. F., Duan, J., Sanders, A. R., Zheng, Y., Pe’er, I., Dudbridge, F., Holmans, P., Whittemore, A. S., Mowry, B. J., et al. (2009) · Nature · doi:10.1038/nature08192 · Cited by 1,154 · see citing works

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

Breier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · see citing works

The Mirtron Pathway Generates microRNA-Class Regulatory RNAs in Drosophila

Okamura, K., Hagen, J. W., Duan, H., Tyler, D. M., & Lai, E. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.028 · Cited by 1,028 · see citing works

The Nature of Dopamine Dysfunction in Schizophrenia and What This Means for Treatment: Meta-analysis of Imaging Studies

Howes, O. D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., & Kapur, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2012.169 · Cited by 967 · see citing works

Sequence Variants in <i>SLITRK1</i> Are Associated with Tourette's Syndrome

Abelson, J. F., Kwan, K. Y., O'Roak, B. J., Baek, D. Y., Stillman, A. A., Morgan, T. M., Mathews, C. A., Pauls, D. L., Rašin, M.-R., Gunel, M., et al. (2005) · Science · doi:10.1126/science.1116502 · Cited by 940 · see citing works

Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor

Duan, J. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg055 · Cited by 916 · see citing works

Dopamine receptors and the dopamine hypothesis of schizophrenia

Seeman, P. M. (1987) · Synapse · doi:10.1002/syn.890010203 · Cited by 880 · see citing works

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

Seeman, P., & Lee, T. (1975) · Science · doi:10.1126/science.1145194 · Cited by 869 · see citing works

miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay

Djuranović, S., Nahvi, A., & Green, R. (2012) · Science · doi:10.1126/science.1215691 · Cited by 866 · see citing works

Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort.

Abi-Dargham, A., Gil, R. B., Krystal, J., Baldwin, R., Seibyl, J., Bowers, M., van Dyck, C., Charney, D., Innis, R., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 860 · see citing works

Dopaminergic modulation of synaptic transmission in cortex and striatum

Tritsch, N. X., & Sabatini, B. L. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.023 · Cited by 756 · see citing works

Induced Pluripotent Stem Cell Generation Using a Single Lentiviral Stem Cell Cassette

Sommer, C. A., Stadtfeld, M., Murphy, G. J., Hochedlinger, K., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1634/stemcells.2008-1075 · Cited by 676 · see citing works

Genetic triple dissociation reveals multiple roles for dopamine in reinforcement learning

Frank, M. J., Moustafa, A. A., Haughey, H. M., Curran, T., & Hutchison, K. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706111104 · Cited by 669 · see citing works

Dopamine in Drug Abuse and Addiction: Results of Imaging Studies and Treatment Implications

Volkow, N. D., Fowler, J. S., Wang, G.-J., Swanson, J. M., & Telang, F. (2007) · Archives of Neurology · doi:10.1001/archneur.64.11.1575 · Cited by 605 · see citing works

Recognition and cleavage of primary microRNA precursors by the nuclear processing enzyme Drosha

Zeng, Y., Yi, R., & Cullen, B. R. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600491 · Cited by 566 · see citing works

The dopamine hypothesis of schizophrenia: focus on the dopamine receptor

Snyder, S. H. (1976) · American Journal of Psychiatry · doi:10.1176/ajp.133.2.197 · Cited by 557 · see citing works

Experimental strategies for microRNA target identification

Thomson, D. W., Bracken, C. P., & Goodall, G. J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr330 · Cited by 544 · see citing works

Provocative tests with psychostimulant drugs in schizophrenia

Lieberman, J. A., Kane, J. M., & Alvir, J. (1987) · Psychopharmacology · doi:10.1007/bf00216006 · Cited by 535 · see citing works

Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning

Kellendonk, C., Simpson, E. H., Polan, H. J., Malleret, G., Vronskaya, S., Winiger, V., Moore, H., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.023 · Cited by 520 · see citing works

A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia

Arinami, T. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.4.577 · Cited by 455 · see citing works

Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory

Zhang, Y., Bertolino, A., Fazio, L., Blasi, G., Rampino, A., Romano, R., Lee, M. T., Xiao, T., Papp, A. C., Wang, D., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707106104 · Cited by 427 · see citing works

Increased Brain Dopamine and Dopamine Receptors in Schizophrenia

Mackay, A. V. P. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290090001001 · Cited by 399 · see citing works

Experimental validation of miRNA targets

Kuhn, D. E., Martin, M. M., Feldman, D. S., Terry, A. V., Nuovo, G. J., & Elton, T. S. (2007) · Methods · doi:10.1016/j.ymeth.2007.09.005 · Cited by 390 · see citing works

Allele-Specific Targeting of microRNAs to HLA-G and Risk of Asthma

Tan, Z., Randall, G. C., Fan, J., Camoretti-Mercado, B., Brockman‐Schneider, R. A., Pan, L., Solway, J., Gern, J. E., Lemanske, R. F., Nicolae, D. L., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/521200 · Cited by 366 · see citing works

Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to Phenotypes

Sethupathy, P., Borel, C., Gagnebin, M., Grant, G. R., Deutsch, S., Elton, T. S., Hatzigeorgiou, A. G., & Antonarakis, S. E. (2007) · The American Journal of Human Genetics · doi:10.1086/519979 · Cited by 361 · see citing works

No Significant Association of 14 Candidate Genes With Schizophrenia in a Large European Ancestry Sample: Implications for Psychiatric Genetics

Sanders, A. R., Duan, J., Levinson, D. F., Shi, J., He, D., Hou, C., Burrell, G. J., Rice, J. P., Nertney, D. A., Olincy, A., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07101573 · Cited by 349 · see citing works

Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells

Ferretti, E., Smaele, E. D., Miele, E., Laneve, P., Pò, A., Pelloni, M., Paganelli, A., Marcotullio, L. D., Caffarelli, E., Screpanti, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.172 · Cited by 331 · see citing works

miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells

Sun, G., Ye, P., Murai, K., Lang, M., Li, S., Zhang, H., Li, W., Fu, C., Yin, J., Wang, A., et al. (2011) · Nature Communications · doi:10.1038/ncomms1532 · Cited by 306 · see citing works

Schizophrenia: More dopamine, more D ₂ receptors

Seeman, P., & Kapur, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.14.7673 · Cited by 279 · see citing works

Polymorphisms within micro-RNA-binding sites and risk of sporadic colorectal cancer

Landi, D., Gemignani, F., Naccarati, A., Pardini, B., Vodička, P., Vodičková, Ľ., Novotný, J. P., Försti, A., Hemminki, K., Canzian, F., et al. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm304 · Cited by 278 · see citing works

Excision of Reprogramming Transgenes Improves the Differentiation Potential of iPS Cells Generated with a Single Excisable Vector

Sommer, C., Sommer, A. G., Longmire, T. A., Christodoulou, C., Thomas, D. D., Gostissa, M., Alt, F. W., Murphy, G. J., Kotton, D. N., & Mostoslavsky, G. (2009) · Stem Cells · doi:10.1002/stem.255 · Cited by 269 · see citing works

Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers

Yu, Z., Li, Z., Jolicoeur, N., Zhang, L., Fortin, Y., Wang, E., Wu, M., & Shen, S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm480 · Cited by 259 · see citing works

C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo

Hirvonen, M., Laakso, A., Någren, K., Rinne, J. O., Pohjalainen, T., & Hietala, J. A. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001561 · Cited by 248 · see citing works

Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics

Mita, T., Hanada, S., Nishino, N., Kuno, T., Nakai, H., Yamadori, T., Mizoi, Y., & Tanaka, C. (1986) · Biological Psychiatry · doi:10.1016/0006-3223(86)90332-x · Cited by 222 · see citing works

D2 dopamine receptors and personality traits

Farde, L., Gustavsson, P. J., & Jönsson, E. G. (1997) · Nature · doi:10.1038/385590a0 · Cited by 217 · see citing works

The Neuronal MicroRNA miR-326 Acts in a Feedback Loop with Notch and Has Therapeutic Potential against Brain Tumors

Kefas, B. A., Comeau, L., Floyd, D. H., Seleverstov, O., Godlewski, J. A., Schmittgen, T., Jiang, J., diPierro, C. G., Li, Y., Chiocca, E. A., et al. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.4966-09.2009 · Cited by 216 · see citing works

Validation of schizophrenia-associated genes CSMD1, C10orf26, CACNA1C and TCF4 as miR-137 targets

Kwon, E., Wang, W., & Tsai, L.-H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2011.170 · Cited by 200 · see citing works

Identification of microRNA-regulated gene networks by expression analysis of target genesPreprint

Gennarino, V. A., D’Angelo, G., Dharmalingam, G., Fernandez, S., Russolillo, G., Sanges, R., M, M., Belcastro, V., Ballabio, A., VERDE, P., et al. (2012) · Genome Research · doi:10.1101/gr.130435.111 · Cited by 200 · see citing works

No structural mutation in the dopamine D2 receptor gene in alcoholism or schizophrenia. Analysis using denaturing gradient gel electrophoresis

Gejman, P. V. (1994) · JAMA · doi:10.1001/jama.271.3.204 · Cited by 187 · see citing works

Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies

Abi-Dargham, A., & Laruelle, M. (2005) · European Psychiatry · doi:10.1016/j.eurpsy.2004.11.003 · Cited by 179 · see citing works

MicroRNA-9: Functional evolution of a conserved small regulatory RNA

Yuva-Aydemir, Y., Simkin, A., Gascon, E., & Gao, F.-B. (2011) · RNA Biology · doi:10.4161/rna.8.4.16019 · Cited by 156 · see citing works

Intronic Polymorphisms Affecting Alternative Splicing of Human Dopamine D2 Receptor Are Associated with Cocaine Abuse

Moyer, R. A., Wang, D., Papp, A. C., Smith, R. M., Duque, L., Mash, D. C., & Sadée, W. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.208 · Cited by 146 · see citing works

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex

Guella, I., Sequeira, A., Rollins, B. L., Morgan, L., Torri, F., van Erp, T. G. M., Myers, R., Barchas, J. D., Schatzberg, A. F., Watson, S. J., et al. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.05.021 · Cited by 132 · see citing works

Functional Analysis of the Human D2 Dopamine Receptor Missense Variants

Cravchik, A., Sibley, D. R., & Gejman, P. V. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.42.26013 · Cited by 127 · see citing works

Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia

Glatt, S. J., Faraone, S. V., & Tsuang, M. T. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001321 · Cited by 126 · see citing works

Dopamine D2 densities and the schizophrenic brain

Zakzanis, K. K., & Hansen, K. T. (1998) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00041-3 · Cited by 122 · see citing works

ZNF804a Regulates Expression of the Schizophrenia-Associated Genes PRSS16, COMT, PDE4B, and DRD2

Girgenti, M. J., LoTurco, J. J., & Maher, B. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032404 · Cited by 110 · see citing works

Prefrontal Cortical Circuits in Schizophrenia

Volk, D. W., & Lewis, D. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_44 · Cited by 106 · see citing works

MicroRNA let-7d regulates the TLX/microRNA-9 cascade to control neural cell fate and neurogenesis

Zhao, C., Sun, G., Ye, P., Li, S., & Shi, Y. (2013) · Scientific Reports · doi:10.1038/srep01329 · Cited by 105 · see citing works

An Association Analysis of Circadian Genes in Anxiety Disorders

Sipilä, T., Kananen, L., Greco, D., Donner, J., Silander, K., Terwilliger, J. D., Auvinen, P., Peltonen, L., Lönnqvist, J. K., Pirkola, S. P., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.12.011 · Cited by 96 · see citing works

Experimental validation of candidate schizophrenia gene ZNF804A as target for hsa-miR-137

Kim, A. H., Parker, E. K., Williamson, V. S., McMichael, G. O., Fanous, A. H., & Vladimirov, V. I. (2012) · Schizophrenia Research · doi:10.1016/j.schres.2012.06.038 · Cited by 90 · see citing works

The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.

Zhang, L. J., Lachowicz, J. E., & Sibley, D. R. (1994) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10202-2 · Cited by 81 · see citing works

Genome-wide survey of interindividual differences of RNA stability in human lymphoblastoid cell lines

Duan, J., Shi, J., Ge, X., Dölken, L., Moy, W., S, D. H. B., Shi, S., Sanders, A. R., Ross, J., & Gejman, P. V. (2013) · Scientific Reports · doi:10.1038/srep01318 · Cited by 81 · see citing works

D2 receptor overexpression in the striatum leads to a deficit in inhibitory transmission and dopamine sensitivity in mouse prefrontal cortex

Li, Y.-C., Kellendonk, C., Simpson, E. H., Kandel, E. R., & Gao, W.-J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1109718108 · Cited by 78 · see citing works

C957T polymorphism of the dopamine D2 receptor gene modulates the effect of nicotine on working memory performance and cortical processing efficiency

Jacobsen, L. K., Pugh, K. R., Mencl, W. E., & Gelernter, J. E. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0469-1 · Cited by 77 · see citing works

Disrupted Pattern of D2 Dopamine Receptors in the Temporal Lobe in Schizophrenia

Goldsmith, S. K. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830190077008 · Cited by 71 · see citing works

Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction

Sullivan, D., Pinsonneault, J. K., Papp, A. C., Zhu, H., Lemeshow, S. A., Mash, D. C., & Sadée, W. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.146 · Cited by 70 · see citing works

Transcriptional Activation of the Human Brain-derived Neurotrophic Factor Gene Promoter III by Dopamine Signaling in NT2/N Neurons

Fang, H., Chartier, J., Sodja, C., Desbois, A., Ribecco‐Lutkiewicz, M., Walker, P. R., & Sikorska, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211539200 · Cited by 61 · see citing works

Performance in the Wisconsin Card Sorting Test and the C957T Polymorphism of the DRD2 Gene in Healthy Volunteers

Rodríguez–Jiménez, R., Hoenicka, J., Jiménez‐Arriero, M. Á., Ponce, G., Bagney, A., Aragüés, M., & Palomo, T. (2006) · Neuropsychobiology · doi:10.1159/000098652 · Cited by 54 · see citing works

Association between a promoter dopamine D2 receptor gene variant and the personality trait detachment

Jönsson, E. G., Cichon, S., Gustavsson, P. J., Grünhage, F., Forslund, K., Mattila‐Evenden, M., Rylander, G., Åsberg, M., Farde, L., Propping, P., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01732-8 · Cited by 47 · see citing works

Identification of functional dopamine receptors in human teratocarcinoma NT2 cells

Sodja, C., Fang, H., Dasgupta, T., Ribecco, M. T. S., Walker, P. R., & Sikorska, M. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(01)00324-2 · Cited by 46 · see citing works

Determining the oxidation states of manganese in NT2 cells and cultured astrocytes

Gunter, K. K., Aschner, M., Miller, L. M., Eliseev, R. A., Salter, J. D., Anderson, K. L., & Gunter, T. E. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.003 · Cited by 39 · see citing works

Schizophrenia: elevated mRNA for dopamine D2Longer receptors in frontal cortex

Tallerico, T., Novak, G., Liu, I. S. C., Ulpian, C., & Seeman, P. M. (2001) · Molecular Brain Research · doi:10.1016/s0169-328x(00)00293-x · Cited by 36 · see citing works

Human iPS cell derivation/reprogramming.

Park, I.-H., & Daley, G. (2009) · Current protocols in stem cell biology · doi:10.1002/9780470151808.sc04a01s8 · Cited by 31 · see citing works

Depressive rumination and the C957T polymorphism of the DRD2 gene

Whitmer, A. J., & Gotlib, I. H. (2012) · Cognitive, Affective, &amp; Behavioral Neuroscience · doi:10.3758/s13415-012-0112-z · Cited by 30 · see citing works

Influence of retinoic acid and lithium on proliferation and dopaminergic potential of human NT2 cells

Misiuta, I. E., Saporta, S., Sanberg, P. R., Žigová, T., & Willing, A. E. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20718 · Cited by 27 · see citing works

Proceedings: Drugs, neurotransmitters, and psychosis.

Sh, S. (1974) · PubMed · Cited by 8 · see citing works

A DRD2 polymorphism predicts PANSS score variability in schizophrenia patients treated with antipsychotics

Voisey, J., Swagell, C. D., Hughes, I. P., Barnes, M., Burton, S. C., van Daal, A., Morris, C. P., Lawford, B. R., & Young, R. M. (2010) · Psychiatry Research · doi:10.1016/j.psychres.2010.02.015 · Cited by 5 · see citing works

Altering the course of schizophrenia: progress and perspectives

Millan, M. J., Andrieux, A., Bartzokis, G., Cadenhead, K., Dazzan, P., Fusar-Poli, P., Gallinat, J., Giedd, J., Grayson, D. R., Heinrichs, M., et al. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.28 · Cited by 516 · see citing works

Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

Martel, J., & McArthur, S. G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01003 · Cited by 231 · see citing works

Second-Generation Antipsychotics and Dysregulation of Glucose Metabolism: Beyond Weight Gain

Grajales, D., Ferreira, V., & Valverde, Á. M. (2019) · Cells · doi:10.3390/cells8111336 · Cited by 181 · see citing works

MicroRNAs: Small molecules with big roles in neurodevelopment and diseases

Sun, E., & Shi, Y. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.08.005 · Cited by 178 · see citing works

Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci

Forrest, M. P., Zhang, H., Moy, W., McGowan, H., Leites, C., Dionisio, L. E., Xu, Z., Shi, J., Sanders, A. R., Greenleaf, W. J., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.07.008 · Cited by 118 · see citing works

A Rare Functional Noncoding Variant at the GWAS-Implicated MIR137/MIR2682 Locus Might Confer Risk to Schizophrenia and Bipolar Disorder

Duan, J., Shi, J., Fiorentino, A., Leites, C., Chen, X., Moy, W., Chen, J., Alexandrov, B. S., Usheva, A., S, D. H. B., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.11.001 · Cited by 104 · see citing works

Analyzing the Role of MicroRNAs in Schizophrenia in the Context of Common Genetic Risk Variants

Hauberg, M. E., Roussos, P., Grove, J., Børglum, A. D., & Mattheisen, M. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3018 · Cited by 102 · see citing works

Perfluorooctane Sulfonate (PFOS) Exposure Could Modify the Dopaminergic System in Several Limbic Brain Regions

Salgado, R., López-Doval, S., Pereiro, N., & Lafuente, A. (2016) · Toxicology Letters · doi:10.1016/j.toxlet.2015.10.023 · Cited by 58 · see citing works

Polymorphisms Falling Within Putative miRNA Target Sites in the 3′UTR Region ofSIRT2andDRD2Genes Are Correlated With Human Longevity

Crocco, P., Montesanto, A., Passarino, G., & Rose, G. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glv058 · Cited by 51 · see citing works

MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets.

Zhang, H., Du, Y., Chen, L., Yuan, Z.-Q., & Cheng, Y. (2023) · Neuroscience and Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105064 · Cited by 43 · see citing works

MicroRNAs in Neurocognitive Dysfunctions: New Molecular Targets for Pharmacological Treatments?

Nadim, W. D., Simion, V., Bénédetti, H., Pichon, C., Baril, P., & Morisset‐Lopez, S. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160709001441 · Cited by 46 · see citing works

Heterogeneity and Individuality: microRNAs in Mental Disorders

Hommers, L. G., Domschke, K., & Deckert, J. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-014-1338-4 · Cited by 45 · see citing works

MicroRNA‐326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease

Zhao, X., Wang, Y., Yang, J., Liu, H., & Wang, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28761 · Cited by 42 · see citing works

PINK1 Deficiency Decreases Expression Levels of mir-326, mir-330, and mir-3099 during Brain Development and Neural Stem Cell Differentiation

Choi, I., Woo, J. H., Jou, I., & Joe, E.-H. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.1.14 · Cited by 40 · see citing works

The roles of MicroRNAs in neural regenerative medicine

Tang, X., & Sun, C. (2020) · Experimental Neurology · doi:10.1016/j.expneurol.2020.113394 · Cited by 40 · see citing works

Role of microRNAs in the pathophysiology of addiction

Gowen, A. M., Odegaard, K. E., Hernandez, J. B., Chand, S., Koul, S., Pendyala, G., & Yelamanchili, S. V. (2020) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1637 · Cited by 40 · see citing works

Modulation of Neuro-Dopamine Homeostasis in Juvenile Female Atlantic Cod (Gadus morhua) Exposed to Polycyclic Aromatic Hydrocarbons and Perfluoroalkyl Substances

Khan, E. A., Bertotto, L. B., Dale, K., Lille‐Langøy, R., Yadetie, F., Karlsen, O. A., Goksøyr, A., Schlenk, D., & Arukwe, A. (2019) · Environmental Science & Technology · doi:10.1021/acs.est.9b00637 · Cited by 33 · see citing works

MicroRNAs and Synaptic Plasticity: From Their Molecular Roles to Response to Therapy

Mohammadi, A. H., Seyedmoalemi, S., Moghanlou, M., Akhlagh, S. A., Talaei, S. A., Hamblin, M. R., Jafari, A., & Mirzaei, H. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02907-2 · Cited by 33 · see citing works

Early Life Stress and the Onset of Obesity: Proof of MicroRNAs’ Involvement Through Modulation of Serotonin and Dopamine Systems’ Homeostasis

Tavares, G. A., Torres, A., & de Souza, J. A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00925 · Cited by 28 · see citing works

MicroRNAs in β-thalassemia

Wang, F., Ling, L., & Yu, D. (2021) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2021.02.011 · Cited by 26 · see citing works

Noncoding RNAs and Midbrain DA Neurons: Novel Molecular Mechanisms and Therapeutic Targets in Health and Disease

Pascale, E., Divisato, G., Palladino, R., Auriemma, M., Ngalya, E. F., & Caiazzo, M. (2020) · Biomolecules · doi:10.3390/biom10091269 · Cited by 24 · see citing works

Impact of recent innovations in the use of mass cytometry in support of drug development

Nassar, A. F., Ogura, H., & Wisnewski, A. V. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2015.06.001 · Cited by 23 · see citing works

Potential involvement of the interleukin-18 pathway in schizophrenia

Xu, Y. J., Yue, W., Shugart, Y. Y., Yuan, J., Wang, G., Wang, H. Z., Lehrman, B., Zhang, F., & Zhang, D. (2015) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2015.12.013 · Cited by 20 · see citing works

Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System

Carrick, W. T., Burks, B., Cairns, M. J., & Kocerha, J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00069 · Cited by 19 · see citing works

Cell type-specific and cross-population polygenic risk score analyses of MIR137 gene pathway in schizophrenia

Yao, Y., Guo, W., Zhang, S., Yu, H., Yan, H., Zhang, H., Sanders, A. R., Yue, W., & Duan, J. (2021) · iScience · doi:10.1016/j.isci.2021.102785 · Cited by 18 · see citing works

Are FXR Family Proteins Integrators of Dopamine Signaling and Glutamatergic Neurotransmission in Mental Illnesses?

Khlghatyan, J., & Beaulieu, J. (2018) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2018.00022 · Cited by 17 · see citing works

MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3′UTR –12 bp to + 154 bp

Wu, X., Xu, F., Xia, X., Wang, B., & Yao, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1703729 · Cited by 17 · see citing works

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease

Mohammed, O. A., Elballal, M. S., El-Husseiny, A. A., Khidr, E. G., Tabaa, M. M. E., Elazazy, O. E., Abd‐Elmawla, M. A., Elesawy, A. E., Ibrahim, H. M., Abulsoud, A. I., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155023 · Cited by 16 · see citing works

TP53 Polymorphism Contributes to the Susceptibility to Bipolar Disorder but Not to Schizophrenia in the Chinese Han Population

Yang, J., Wu, X., Huang, J., Chen, Z., Huang, G., Guo, X., Zhu, L., & Su, L. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01330-y · Cited by 16 · see citing works

MicroRNAs in Dopamine Agonist-Resistant Prolactinoma

Wan, X., Yan, Z., Tan, Z., Cai, Z. M., Qi, Y., Lü, L., Xu, Y., Chen, J., & Lei, T. (2021) · Neuroendocrinology · doi:10.1159/000517356 · Cited by 15 · see citing works

Investigation of Schizophrenia with Human Induced Pluripotent Stem Cells

Powell, S. K., O’Shea, C. P., Shannon, S. R., Akbarian, S., & Brennand, K. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-45493-7_6 · Cited by 15 · see citing works

Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences

Blum, K., Bowirrat, A., Baron, D., Elman, I., Makale, M. T., Cadet, J. L., Thanos, P. K., Hanna, C., Ahmed, R., Gondre-Lewis, M. C., et al. (2024) · Gene &amp; Protein in Disease · doi:10.36922/gpd.1966 · Cited by 14 · see citing works

Implications of SNP-triggered miRNA dysregulation in Schizophrenia development

Mohamed, F. A., & Freude, K. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1321232 · Cited by 14 · see citing works

Path from schizophrenia genomics to biology: gene regulation and perturbation in neurons derived from induced pluripotent stem cells and genome editing

Duan, J. (2015) · Neuroscience Bulletin · doi:10.1007/s12264-014-1488-2 · Cited by 14 · see citing works

Genetic variation in the miR‐708 gene and its binding targets in bipolar disorder

Fiorentino, A., O’Brien, N. L., Sharp, S. I., Curtis, D., Bass, N. J., & McQuillin, A. (2016) · Bipolar Disorders · doi:10.1111/bdi.12448 · Cited by 13 · see citing works

A Dishful of a Troubled Mind: Induced Pluripotent Stem Cells in Psychiatric Research

Kálmán, S., Hathy, E., & Réthelyi, J. (2015) · Stem Cells International · doi:10.1155/2016/7909176 · Cited by 13 · see citing works

Identification of rare and common variants in BNIP3L: a schizophrenia susceptibility gene

Zhou, J., Ma, C., Wang, K., Li, X., Jian, X.-M., Zhang, H., Yuan, J., Yin, J., Chen, J.-H., & Shi, Y.-Y. (2020) · Human Genomics · doi:10.1186/s40246-020-00266-4 · Cited by 14 · see citing works

Pharmacogenomics in Psychiatric Practice

El‐Mallakh, R. S., Roberts, R. J., El-Mallakh, P. L., Findlay, L., & Reynolds, K. K. (2016) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2016.05.001 · Cited by 12 · see citing works

Phosphoinositide-3-kinase regulatory subunit 1 gene polymorphisms are associated with schizophrenia and bipolar disorder in the Han Chinese population

Huang, J., Chen, Z., Zhu, L., Wu, X., Guo, X., Yang, J., Long, J., & Su, L. (2020) · Metabolic Brain Disease · doi:10.1007/s11011-020-00552-z · Cited by 11 · see citing works

miR-9-5p deficiency contributes to schizophrenia

Fu, X., Baranova, A. V., Cao, H., Liu, Y., Sun, J., & Zhang, F. (2023) · Schizophrenia Research · doi:10.1016/j.schres.2023.11.006 · Cited by 10 · see citing works

Transcriptome outlier analysis implicates schizophrenia susceptibility genes and enriches putatively functional rare genetic variants

Duan, J., Sanders, A. R., Moy, W., Drigalenko, E. I., Brown, E. C., Freda, J., Leites, C., Göring, H. H. H., MGS, & Gejman, P. V. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv199 · Cited by 10 · see citing works

Diseases and their clinical heterogeneity – Are we ignoring the SNiPers and micRomaNAgers? An illustration using Beta-thalassemia clinical spectrum and fetal hemoglobin levels

Das, S. S., Mitra, A., & Chakravorty, N. (2018) · Genomics · doi:10.1016/j.ygeno.2018.01.002 · Cited by 10 · see citing works

The Role of MIR9-2 in Shared Susceptibility of Psychiatric Disorders during Childhood: A Population-Based Birth Cohort Study

Tovo‐Rodrigues, L., Quinte, G. C., Brum, C. B., Ghisleni, G., Bastos, C. R., Oliveira, I. O., Barros, F. C., Barros, A. J. D., Santos, I. S., Rohde, L. A., et al. (2019) · Genes · doi:10.3390/genes10080626 · Cited by 8 · see citing works

Molecular Profiling of Human Induced Pluripotent Stem Cell ‐Derived Hypothalamic Neurones Provides Developmental Insights into Genetic Loci for Body Weight Regulation

Yao, L., Liu, Y., Qiu, Z., Kumar, S. U., Curran, J. E., Blangero, J., Chen, Y., & Lehman, D. M. (2017) · Journal of Neuroendocrinology · doi:10.1111/jne.12455 · Cited by 7 · see citing works

Rs7219 Regulates the Expression of GRB2 by Affecting miR-1288-Mediated Inhibition and Contributes to the Risk of Schizophrenia in the Chinese Han Population

Yang, J., Guo, X., Zhu, L., Huang, J., Long, J., Chen, Q., Pan, R., Chen, Z., Wu, X., & Su, L. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0639-9 · Cited by 7 · see citing works

hsa-miR-3177-5p and hsa-miR-3178 Inhibit 5-HT1A Expression by Binding the 3′-UTR Region in vitro

Wu, X., Ding, M., Liu, Y., Xia, X., Xu, F., Yao, J., & Wang, B. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00013 · Cited by 7 · see citing works

Rare and common variants analysis of the EMB gene in patients with schizophrenia

Zhou, J., Ma, C., Wang, K., Li, X., Zhang, H., Chen, J.-H., Li, Z.-Q., & Shi, Y.-Y. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02513-3 · Cited by 7 · see citing works

The Role of microRNAs in Alcoholism: A Meta-analytic Review

Mohebbati, R., & Sadeghnia, H. R. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666220520112928 · Cited by 6 · see citing works

Genetic variation in the 3′-untranslated region of PAK1 influences schizophrenia susceptibility

Jiang, J., Long, J., Ling, W., Huang, G., & Su, L. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4039 · Cited by 5 · see citing works

The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry

Montel Hayes, R., Mason, C. E., & Miller, J. J. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1671122 · Cited by 5 · see citing works

MicroRNAs as promising therapeutic agents: A perspective from acupuncture

Li, S., Huang, Q., Yang, Q., Peng, X., & Wu, Q. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154652 · Cited by 4 · see citing works

Drug Addictions and Genetics of the Dopamine Pathway

Strat, Y. L., Ramoz, N., & Gorwood, P. A. P. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800634-4.00018-4 · Cited by 4 · see citing works

MicroRNA-281-X Modulates Self-Grooming Behavior in Honeybees by Targeting Tyrosine Decarboxylase 2 in the Octopaminergic Pathway

Lü, Y., Ouyang, W., Liao, J., Miao, L., Li, Z., & Su, S. (2026) · Insects · doi:10.3390/insects17050522 · Cited by 2 · see citing works

MicroRNA dysregulation in glutamate and dopamine pathways of schizophrenia: From molecular pathways to diagnostic and therapeutic approaches

Khosroshahi, P. A., & Ghanbari, M. (2024) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2024.111081 · Cited by 3 · see citing works

Small RNA Dysregulation in Neurocognitive and Neuropsychiatric Disorders

Geaghan, M. P., & Cairns, M. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804402-5.00013-3 · Cited by 2 · see citing works

A new aspect on the correlation of ten SNPs in MIR and their target genes in dopaminergic pathways in schizophrenia

Molaei, A., Agahi, M., Malekian, M., Moradhasel, B., Tajrezaee, A., Lajevardi, A., Salahshourifar, I., Hezaveh, N. M., Javadi, G., & Noormohammadi, Z. (2022) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-022-00744-w · Cited by 2 · see citing works

Unveiling the ‘Eating Poison’ of Polygala tenuifolia xylem: Mood changes and myocardial injury

Zhang, F., Zhang, L., Mao, W., Ma, Y., Lou, Y., Li, X., Liu, H., Zhao, L., Guo, D., & Li, Z. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101466 · Cited by 1 · see citing works

Faculty Opinions recommendation of Open Chromatin Profiling in hiPSC-Derived Neurons Prioritizes Functional Noncoding Psychiatric Risk Variants and Highlights Neurodevelopmental Loci.

Kroll, K. L., & Antony, I. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.728639315.793576986

Metabolic stress and antipsychotic treatment induced gene expression alterations in human cell

Kálmán, S. (2016) · doi:10.14232/phd.2988

Additional file 1 of Rare and common variants analysis of the EMB gene in patients with schizophrenia

Zhou, J., Ma, C., Wang, K., Li, X., Zhang, H., Chen, J., Li, Z., & Shi, Y. (2020) · Figshare · doi:10.6084/m9.figshare.12032946

Integrative ceRNA network analysis in monozygotic twins reveals shared and disorder-specific molecular signatures in major psychiatric disorders

Lu, C., Bi, J., Liu, R., Lan, J., He, Y., Ni, C., Xd, W., & Zhao, C. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-07894-5

Contrôle central du comportement alimentaire chez le rat : effets du sevrage précoce et de la supplémentation orale aiguë en MIR-320-3p et MiR-375-3p pendant la période postnatale

Tavares, G. A. (2021) · theses.fr (ABES) · doi:10.70675/10488f95z6e5bz45caz916fz409fe8e55347

MicroRNA-15a, microRNA-15b and microRNA-16 inhibit the human dopamine D1 receptor expression in four cell lines by targeting 3′UTR –12 bp to + 154 bp

Wu, X., Xu, F., Xia, X., Wang, B., & Yao, J. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1703729 · Cited by 17 · see citing works

Differential Allelic Expression of Dopamine D1 Receptor Gene (DRD1) Is Modulated by microRNA miR-504

Huang, W., & Li, M. D. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.024 · Cited by 121 · see citing works

PP27 Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence

Spahn, M., Kneitz, S., Scholz, C. J., Stenger, N., Rüdiger, T., Ströbel, P., Riedmiller, H. N., & Kneitz, B. (2009) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(09)72211-6 · Cited by 1 · see citing works

Sleep Deprivation Increased Dopamine D2 Receptor Expression through Downregulation of miR-9

Wen, R., Chen, X., Huang, D., Chen, M., & Liu, Y. (2015) · International Conference on Information Technology in Medicine and Education · doi:10.1109/itme.2015.122 · Cited by 3 · see citing works

DARPP-32, DRD1, SLC6A3, and CK2

Shapshak, P. (2013)